George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXPD.L Regulatory News (XPD)

  • There is currently no data for XPD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8 (OPD) - Xpediator plc - Replacement

5 Jan 2023 13:14

RNS Number : 8442L
Cogels Investments Limited
05 January 2023
 

Replacement - Form 8 (OPD) - Xpediator plc

 

This announcement replaces the Form 8 (OPD) announcement released by Cogels Investments Limited on 4 January 2023 at 15:14 (GMT) under RNS 7035L.

 

Sections 1, 2, 3 and 4 have been updated.

 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

A consortium comprising Cogels Investments Limited, funds managed by BaltCap and Justas Versnickas.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

Cogels Investments Limited, the investment vehicle of Stephen Blyth.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Xpediator plc

(d) Is the discloser the offeror or the offeree?

Offeror

(e) Date position held:

The latest practicable date prior to the disclosure

30 December 2022

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

5p ordinary shares

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

37,260,660*

 

26.30

 

 

(2) Cash-settled derivatives:

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

TOTAL:

37,260,660

26.30

 

 

 

All interests and all short positions should be disclosed.

\* The relevant securities referred to above are held directly by Cogels Investments Limited.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

 

The persons listed below are either a director of Cogels Investments Limited or a close relative of a director of Cogels Investments Limited.

 

Name

Number of ordinary shares of 5p each held

Percentage of issued share capital

Lucia Blyth

104,077

0.07%

Claudia Blyth

104,077

0.07%

Olivia Blyth

104,077

0.07%

Emilia Blyth

104,077

0.07%

George Blyth

104,077

0.07%

Frances Lee

31,223

0.02%

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None.

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None.

 

 

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

5 January 2023

Contact name:

Stephen Blyth

Telephone number:

+44 7801 662486

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEBAMJTMTMMBLJ
Date   Source Headline
7th Jul 202310:33 amRNSScheme of Arrangement becomes effective
7th Jul 20237:30 amRNSSuspension - Xpediator plc
6th Jul 20231:01 pmRNSCourt Sanction of the Scheme of Arrangement
5th Jul 20231:57 pmPRNForm 8.3 - Xpediator Plc
4th Jul 20232:52 pmPRNForm 8.3 - Xpediator Plc
4th Jul 202310:57 amRNSDeclaration of special dividend
3rd Jul 20232:40 pmPRNForm 8.3 - Xpediator Plc
30th Jun 202312:58 pmPRNForm 8.3 - Xpediator Plc
29th Jun 20235:54 pmRNSResult of AGM
29th Jun 20232:49 pmPRNForm 8.3 - Xpediator Plc
28th Jun 20233:06 pmRNSOffer update & timetable
28th Jun 20231:30 pmPRNForm 8.3 - Xpediator Plc
27th Jun 202312:48 pmPRNForm 8.3 - Xpediator Plc
26th Jun 202312:12 pmPRNForm 8.3 - Xpediator Plc
26th Jun 20238:00 amRNSHolding(s) in Company
23rd Jun 20233:27 pmPRNForm 8.3 - Xpediator Plc
23rd Jun 20239:46 amRNSForm 8.3 - Xpediator PLC
22nd Jun 20238:39 amRNSOffer update & expected timetable
8th Jun 202311:24 amRNSForm 8.3 - Xpediator PLC
8th Jun 202310:37 amRNSForm 8.3 - XPEDIATOR PLC
7th Jun 20231:25 pmRNSResults of Court Meeting and General Meeting
6th Jun 20239:57 amRNSPosting of Annual Report and Notice of AGM
26th May 20231:08 pmRNSForm 8.3 - Xpediator PLC
23rd May 20237:00 amRNSFinal Results
22nd May 202311:39 amRNSForm 8.3 - Xpediator PLC
9th May 20237:00 amRNSDocuments incorporated by reference – translations
4th May 20237:00 amRNSPosting of scheme document
26th Apr 20234:51 pmRNSForm 8.3 - Xpediator PLC
24th Apr 202312:03 pmRNSHolding(s) in Company
24th Apr 202311:12 amRNSForm 8.3 - Xpediator Plc
24th Apr 202311:03 amRNSHolding(s) in Company
24th Apr 202310:40 amRNSForm 8.3 - XPEDIATOR PLC
24th Apr 20238:19 amRNSForm 8.3 - Xpediator PLC
20th Apr 20239:48 amRNSForm 8.3 - Xpediator PLC
17th Apr 20238:18 amRNSForm 8.3 - Xpediator PLC
6th Apr 20237:00 amRNSRecommended Cash Offer for Xpediator PLC
14th Mar 202310:30 amRNSExtension of deadline under Rule 2.6c of the Code
14th Feb 20234:00 pmRNSExtension of deadline under Rule 2.6c of the Code
13th Feb 202312:32 pmRNSForm 8.3 - Xpediator plc
13th Feb 202311:35 amRNSForm 8.3 - Xpediator plc
3rd Feb 202311:55 amRNSForm 8.3 - Xpediator PLC
3rd Feb 202310:35 amRNSForm 8.3 - Xpediator plc
2nd Feb 20237:00 amRNSTrading Update
16th Jan 20233:38 pmRNSExtension of deadline under Rule 2.6c of the Code
6th Jan 202312:00 pmRNSForm 8.3 - Xpediator plc - Sandu Grigore
6th Jan 202311:06 amRNSForm 8.3 - Xpediator plc - Danor Ionescu
6th Jan 202311:05 amRNSForm 8.3 - Xpediator plc - Shaun Godfrey
6th Jan 20237:00 amRNSForm 8 (OPD) - Xpediator plc
5th Jan 20235:53 pmRNSForm 8.3 - Xpediator PLC
5th Jan 20231:14 pmRNSForm 8 (OPD) - Xpediator plc - Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.